...
CRDFCardiff Oncology, Inc.
$2.79
Analysis updated: Jan 16, 2026

Investment Thesis

CRDF is a market laggard (RS 67/99, Top 33%) with strong fundamentals. avoid chasing - protect capital. Smart traders skip this one until the setup improves.

Weak relative strength + ordinary growth = Pass

Key Takeaways

Earnings Momentum

-19%
Q4'24
$-0.25
-27%
Q1'25
$-0.28
+19%
Q2'25
$-0.21
+32%
Q3'25
$-0.17
Earnings Growing

Price Structure

Partial Alignment
Price
$2.79
50 DMA
$2.48
100 DMA
$2.32
150 DMA
$2.63
200 DMA
$2.72
Alignment Score: 2/4

CRDF Price Chart

Loading chart...

50 DMA150 DMA200 DMA
LEADERSHIP TEST FAILED

RS Rating 67/99 is in Bottom 67% of market. Minervini target: Top 20% (RS 80+)

Why Not BUY Yet?

RS Rating
67 (Top 33%)>80 (Top 20%)
Pattern
No base formingVCP or constructive base
Breakout Status
-4.5% from entry ($2.92)Breakout confirmation (hold above entry)

What Would Change Our Mind?

To turn bullish on CRDF, we need:

Twin Engines Dashboard

Technical Health

RS Rating
67/99
Top 33% (Need 80+)
Trend
Weak Uptrend
Above 200 DMA
RSI (14)
52
NEUTRAL
VCP Setup
COOL
Score: 3/9
Volume
406K
-57% vs avg
From Entry
-4.5%
$2.92

Fundamental Horsepower

EPS Qtr YoY
+32%
Accelerating
EPS 3Y CAGR
N/A
Annual Earnings
Revenue Qtr
-27%
DECLINING
F-Score
3/9
Piotroski Quality
ROE
-60%
Return on Equity
EPS Rank
45/99
Percentile

Trade Plan

Struggling

Broke out 3 weeks ago — now -4.5% from entry.

Below entry. Consider cutting losses or wait for reclaim of $2.92.

Breakout Date2025-12-2225 days ago
Entry Price$2.92-4.5% since
Trail Stop$2.92Breakeven or 21 EMA
Breakout Quality6/10🔥 Volume surge

If/Then Playbook

IF: RS Rating improves to >80
THEN: Re-evaluate for WATCHLIST
IF: Price closes below 200 DMA
THEN: Remove from radar entirely
IF: EPS growth accelerates to >40% next quarter
THEN: Reassess as potential turnaround

Key Price Levels

Resistance

  • 20 DMA$2.88+3.2%
  • 52W High$4.99+78.9%
Current$2.79

Support

  • 200 DMA$2.72-2.5%
  • 50 DMA$2.48-11.2%
  • 52W Low$1.90-31.9%

Frequently Asked Questions

Is CRDF stock a buy now?

CRDF is a market laggard (RS 67/99, Top 33%) with strong fundamentals. avoid chasing - protect capital. Smart traders skip this one until the setup improves.

What is the buy point for CRDF?

CRDF broke out at $2.92 but is flat/slightly down (-4.5%). Monitor for breakout confirmation before entry.

What is CRDF's RS Rating?

CRDF has an RS Rating of 67/99, meaning it's in the Top 33% of all stocks for relative price performance over the past 12 months. Minervini recommends RS 80+ for momentum trades.

Important Disclosure: This analysis is for educational and informational purposes only. Technical and fundamental indicators are based on historical data and do not guarantee future performance. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.